NYSE:MRKPharmaceuticals
Is Merck Still Attractive After Oncology Wins and Strong 5 Year Share Performance in 2025
If you are wondering whether Merck at around $100 a share is still a smart buy, or if most of the upside has already been priced in, you are in the right place.
Merck’s share price has nudged up about 0.6% over the last week and 9.7% in the past month, but that still only translates to roughly 1.1% year to date and 2.0% over the last year, after a stronger 53.7% run over five years.
Recent headlines have centered on Merck’s expanding oncology and vaccine franchises, with regulators...